Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amonafide L-malate + Cytarabine in AML
NCT01066494Phase 2Unknown
- Sponsor
- Antisoma
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of amonafide in acute myeloid leukemia (AML), sponsored by Antisoma. Status: unknown.
02
Drugs
amonafide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01066494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066494.